We are live on ! Find out more
NA

Nordwand Advisors Portfolio holdings

AUM $572M
1-Year Est. Return 23.09%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+23.09%
3 Year Est. Return
+66.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$131M
Cap. Flow
-$137M
Cap. Flow %
-56.57%
Top 10 Hldgs %
95.39%
Holding
147
New
6
Increased
5
Reduced
8
Closed
28

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$391K
2
MSDL icon
Morgan Stanley Direct Lending Fund
MSDL
+$329K
3
AMBP icon
Ardagh Metal Packaging
AMBP
+$93.6K
4
SDP icon
ProShares UltraShort Utilities
SDP
+$15.6K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$10.3K

Top Sells

Rank Stock Value
1
NVCR icon
NovoCure
NVCR
+$57.5M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$49.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$26.6M
4
GRAB icon
Grab
GRAB
+$3.01M
5
MP icon
MP Materials
MP
+$408K

Sector Composition

Rank Sector Weight
1 Financials 45.75%
2 Healthcare 39.21%
3 Technology 6.15%
4 Consumer Discretionary 1.21%
5 Materials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GROV icon
126
Grove Collaborative
GROV
$45.8M
– –
-3,000
Closed -$4.05K
INTZ
127
Intrusion
INTZ
$17.5M
– –
-1,000
Closed -$860
MIR icon
128
Mirion Technologies
MIR
$3.9B
– –
-25,000
Closed -$277K
MRSN
129
DELISTED
Mersana Therapeutics
MRSN
– –
-60
Closed -$2.83K
MURA
130
DELISTED
Mural Oncology
MURA
– –
-1,000
Closed -$3.13K
ORMP icon
131
Oramed Pharmaceuticals
ORMP
$180M
– –
-1,000
Closed -$2.44K
PASG icon
132
Passage Bio
PASG
$14.4M
– –
-125
Closed -$1.75K
PHIO icon
133
Phio Pharmaceuticals
PHIO
$12M
– –
-500
Closed -$1.73K
PMVP icon
134
PMV Pharmaceuticals
PMVP
$59.7M
– –
-2,000
Closed -$2.98K
QSI icon
135
Quantum-Si Incorporated
QSI
$162M
– –
-2,000
Closed -$1.76K
RETO icon
136
ReTo Eco-Solutions
RETO
$24.6M
– –
-10
Closed -$3.02K
RVSN icon
137
Rail Vision
RVSN
$9.1M
– –
-100
Closed -$1.69K
SBFM
138
Sunshine Biopharma
SBFM
$2.78M
– –
-50
Closed -$1.59K
SPB icon
139
Spectrum Brands
SPB
$2.04B
– –
-2,500
Closed -$238K
USEA icon
140
United Maritime
USEA
$25.1M
– –
-400
Closed -$1.04K
USIO icon
141
Usio Inc
USIO
$61.3M
– –
-1,500
Closed -$2.04K
AIFU
142
AIFU Inc
AIFU
$213M
– –
-5
Closed -$2.84K
OCEA
143
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
– –
-2,000
Closed -$1.96K
AY
144
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
– –
-6,000
Closed -$132K
TFFP
145
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
– –
-1,000
Closed -$2.01K
DBGI
146
Digital Brands Group
DBGI
$10.5M
– –
-1
Closed -$504
ATIP
147
DELISTED
ATI Physical Therapy, Inc.
ATIP
– –
-1,500
Closed -$9.15K
2 3 4 5
6

Similar funds

EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $572M AUM 24.16% 1-Year Est. Return
MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Nordwand Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Nordwand Advisors held 147 positions worth $243M, down 35% from $374M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Nordwand Advisors withdrew a net $137M in Q4 2024, closing 28 positions and reducing 8 holdings. Its most notable exit was Mirion Technologies, an estimated $277K position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 43% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nordwand Advisors opened a new position in Morgan Stanley Direct Lending Fund worth $332K.

  • Nordwand Advisors's largest Q4 2024 buy was Morgan Stanley Direct Lending Fund: 16,060 shares worth $332K.
  • Nordwand Advisors added most to NVIDIA in Q4 2024, an estimated $391K increase.
  • Nordwand Advisors's biggest Q4 2024 reduction was NovoCure, cutting an estimated $57.5M.
  • Nordwand Advisors fully exited Mirion Technologies in Q4 2024, selling an estimated $277K.
  • Nordwand Advisors's ten largest holdings make up 95% of its $243M portfolio in Q4 2024.
  • Nordwand Advisors opened 6 new positions and closed 28 in Q4 2024.
  • Nordwand Advisors's portfolio value fell 35% quarter-over-quarter to $243M.

Based on Nordwand Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.